mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.089 |
0.03 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.04 |
mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |